Enecimo, Danzy Dhae F.
HRN: 22-57-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/06/2023
02/13/2023
IV
140mg
Q6hrs
AGE
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes